{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T13:57:13Z","timestamp":1790085433979,"version":"4.0.1"},"reference-count":35,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2014,9,1]],"date-time":"2014-09-01T00:00:00Z","timestamp":1409529600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Small Business Innovative Research (SBIR)","award":["R44CA140047"],"award-info":[{"award-number":["R44CA140047"]}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","gynecologiconcology-online.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gynecologic Oncology"],"published-print":{"date-parts":[[2014,9]]},"DOI":"10.1016\/j.ygyno.2014.06.013","type":"journal-article","created":{"date-parts":[[2014,6,24]],"date-time":"2014-06-24T11:52:58Z","timestamp":1403610778000},"page":"581-590","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":81,"title":["Prognostic analysis of invasive circulating tumor cells (iCTCs) in epithelial ovarian cancer"],"prefix":"10.1016","volume":"134","author":[{"given":"Michael L.","family":"Pearl","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiang","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huan","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaun","family":"Tulley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Golightly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8748-894X","authenticated-orcid":false,"given":"Stanley","family":"Zucker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen-Tien","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ygyno.2014.06.013_bb0005","doi-asserted-by":"crossref","first-page":"11","DOI":"10.3322\/caac.21166","article-title":"Cancer statistics, 2013","volume":"63","author":"Siegel","year":"2013","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.ygyno.2014.06.013_bb0010","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.ygyno.2012.12.024","article-title":"The significance of the pattern of serum CA125 level ascent to above the normal range in epithelial ovarian, primary peritoneal and tubal carcinoma patients","volume":"129","author":"Levy","year":"2013","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ygyno.2014.06.013_bb0015","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.ygyno.2010.07.025","article-title":"CA125 nadir concentration is an independent predictor of tumor recurrence in patients with ovarian cancer: a population-based study","volume":"119","author":"van Altena","year":"2010","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ygyno.2014.06.013_bb0020","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.ygyno.2009.06.038","article-title":"Exploratory analysis of serum CA-125 response to surgery and the risk of relapse in patients with FIGO stage IIIC ovarian cancer","volume":"115","author":"Zivanovic","year":"2009","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ygyno.2014.06.013_bb0025","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1002\/cncr.24084","article-title":"The prognostic value of pretreatment CA 125 in patients with advanced ovarian carcinoma: a Gynecologic Oncology Group study","volume":"115","author":"Zorn","year":"2009","journal-title":"Cancer"},{"key":"10.1016\/j.ygyno.2014.06.013_bb0030","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/j.ygyno.2013.08.006","article-title":"Predictive value of circulating tumor cells (CTCs) in newly-diagnosed and recurrent ovarian cancer patients","volume":"131","author":"Liu","year":"2013","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ygyno.2014.06.013_bb0035","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.ygyno.2012.09.021","article-title":"Molecular characterization of circulating tumor cells in patients with ovarian cancer improves their prognostic significance\u2014a study of the OVCAD consortium","volume":"128","author":"Obermayr","year":"2013","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ygyno.2014.06.013_bb0040","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1186\/1471-2407-13-178","article-title":"A combined blood based gene expression and plasma protein abundance signature for diagnosis of epithelial ovarian cancer\u2014a study of the OVCAD consortium","volume":"13","author":"Pils","year":"2013","journal-title":"BMC Cancer"},{"key":"10.1016\/j.ygyno.2014.06.013_bb0045","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1097\/IGC.0b013e318216cb91","article-title":"Molecular profiling and prognostic relevance of circulating tumor cells in the blood of ovarian cancer patients at primary diagnosis and after platinum-based chemotherapy","volume":"21","author":"Aktas","year":"2011","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.ygyno.2014.06.013_bb0050","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/j.ygyno.2011.05.028","article-title":"Circulating tumor cells predict progression free survival and overall survival in patients with relapsed\/recurrent advanced ovarian cancer","volume":"122","author":"Poveda","year":"2011","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ygyno.2014.06.013_bb0055","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.ygyno.2008.09.021","article-title":"Clinical significance of circulating tumor cells detected by an invasion assay in peripheral blood of patients with ovarian cancer","volume":"112","author":"Fan","year":"2009","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ygyno.2014.06.013_bb0060","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1038\/sj.bjc.6604545","article-title":"Detection of circulating tumour cells in peripheral blood with an automated scanning fluorescence microscope","volume":"99","author":"Ntouroupi","year":"2008","journal-title":"Br J Cancer"},{"key":"10.1016\/j.ygyno.2014.06.013_bb0065","doi-asserted-by":"crossref","first-page":"6897","DOI":"10.1158\/1078-0432.CCR-04-0378","article-title":"Tumor cells circulate in the peripheral blood of all major carcinomas but not in healthy subjects or patients with nonmalignant diseases","volume":"10","author":"Allard","year":"2004","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.ygyno.2014.06.013_bb0070","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.ygyno.2003.08.004","article-title":"Preoperative detection of peripherally circulating cancer cells and its prognostic significance in ovarian cancer","volume":"91","author":"Judson","year":"2003","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ygyno.2014.06.013_bb0075","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1002\/ijc.24814","article-title":"Isolation of circulating epithelial and tumor progenitor cells with an invasive phenotype from breast cancer patients","volume":"126","author":"Lu","year":"2010","journal-title":"Int J Cancer"},{"key":"10.1016\/j.ygyno.2014.06.013_bb0080","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.canlet.2008.12.007","article-title":"Functional phenotyping and genotyping of circulating tumor cells from patients with castration resistant prostate cancer","volume":"277","author":"Paris","year":"2009","journal-title":"Cancer Lett"},{"key":"10.1016\/j.ygyno.2014.06.013_bb0085","doi-asserted-by":"crossref","first-page":"2284","DOI":"10.1002\/ijc.28561","article-title":"Detection and characterization of invasive circulating tumor cells derived from men with metastatic castration-resistant prostate cancer","volume":"134","author":"Friedlander","year":"2014","journal-title":"Int J Cancer"},{"key":"10.1016\/j.ygyno.2014.06.013_bb0090","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1016\/0895-4356(95)00048-8","article-title":"Importance of events per independent variable in proportional hazards regression analysis. II Accuracy and precision of regression estimates","volume":"48","author":"Peduzzi","year":"1995","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.ygyno.2014.06.013_bb0095","series-title":"Modelling survival data in medical research","first-page":"1","author":"Collett","year":"1994"},{"key":"10.1016\/j.ygyno.2014.06.013_bb0100","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1097\/IGC.0b013e3182691254","article-title":"Prognostic significance of rising serum CA-125 levels within the normal range in patients with epithelial ovarian, primary peritoneal, and tubal cancers, who, after initial treatment, had a complete clinical response","volume":"22","author":"Levy","year":"2012","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.ygyno.2014.06.013_bb0105","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.ygyno.2006.07.027","article-title":"CA125 level as a predictor of progression-free survival and overall survival in ovarian cancer patients with surgically defined disease status prior to the initiation of intraperitoneal consolidation therapy","volume":"104","author":"Juretzka","year":"2007","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ygyno.2014.06.013_bb0110","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1038\/nrc3260","article-title":"Screening for cancer with molecular markers: progress comes with potential problems","volume":"12","author":"Baron","year":"2012","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.ygyno.2014.06.013_bb0115","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1007\/s10549-011-1373-x","article-title":"Epithelial\u2013mesenchymal transition and stemness features in circulating tumor cells from breast cancer patients","volume":"130","author":"Raimondi","year":"2011","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.ygyno.2014.06.013_bb0120","doi-asserted-by":"crossref","first-page":"R69","DOI":"10.1186\/bcr2131","article-title":"Enrichment with anti-cytokeratin alone or combined with anti-EpCAM antibodies significantly increases the sensitivity for circulating tumor cell detection in metastatic breast cancer patients","volume":"10","author":"Deng","year":"2008","journal-title":"Breast Cancer Res"},{"key":"10.1016\/j.ygyno.2014.06.013_bb0125","doi-asserted-by":"crossref","first-page":"25ra23","DOI":"10.1126\/scitranslmed.3000403","article-title":"Isolation and characterization of circulating tumor cells from patients with localized and metastatic prostate cancer","volume":"2","author":"Stott","year":"2010","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.ygyno.2014.06.013_bb0130","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1373\/clinchem.2011.175570","article-title":"Circulating epithelial cells in patients with benign colon diseases","volume":"58","author":"Pantel","year":"2012","journal-title":"Clin Chem"},{"key":"10.1016\/j.ygyno.2014.06.013_bb0135","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1002\/(SICI)1097-0215(20000120)89:1<8::AID-IJC2>3.0.CO;2-K","article-title":"Molecular detection of blood-borne epithelial cells in colorectal cancer patients and in patients with benign bowel disease","volume":"89","author":"Hardingham","year":"2000","journal-title":"Int J Cancer"},{"key":"10.1016\/j.ygyno.2014.06.013_bb0140","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/j.ccr.2013.04.017","article-title":"Tumor cell dissemination: emerging biological insights from animal models and cancer patients","volume":"23","author":"Kang","year":"2013","journal-title":"Cancer Cell"},{"key":"10.1016\/j.ygyno.2014.06.013_bb0145","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1038\/nbt.2576","article-title":"Identification of a population of blood circulating tumor cells from breast cancer patients that initiates metastasis in a xenograft assay","volume":"31","author":"Baccelli","year":"2013","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.ygyno.2014.06.013_bb0150","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.ccr.2007.12.003","article-title":"Systemic spread is an early step in breast cancer","volume":"13","author":"Husemann","year":"2008","journal-title":"Cancer Cell"},{"key":"10.1016\/j.ygyno.2014.06.013_bb0155","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1096\/fj.11-180695","article-title":"Fetal progenitor cells naturally transferred through pregnancy participate in inflammation and angiogenesis during wound healing","volume":"26","author":"Nassar","year":"2012","journal-title":"FASEB J"},{"key":"10.1016\/j.ygyno.2014.06.013_bb0160","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1158\/0008-5472.CAN-10-0618","article-title":"Fetal cell microchimerism and cancer: a nexus of reproduction, immunology, and tumor biology","volume":"71","author":"Kallenbach","year":"2011","journal-title":"Cancer Res"},{"key":"10.1016\/j.ygyno.2014.06.013_bb0165","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1073\/pnas.93.2.705","article-title":"Male fetal progenitor cells persist in maternal blood for as long as 27years postpartum","volume":"93","author":"Bianchi","year":"1996","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.ygyno.2014.06.013_bb0170","first-page":"27","article-title":"The multiple personality disorder phenotype(s) of circulating endothelial cells in cancer","volume":"1796","author":"Bertolini","year":"2009","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.ygyno.2014.06.013_bb0175","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1182\/blood-2005-04-1509","article-title":"Unresolved questions, changing definitions, and novel paradigms for defining endothelial progenitor cells","volume":"106","author":"Ingram","year":"2005","journal-title":"Blood"}],"container-title":["Gynecologic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825814010531?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825814010531?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,3]],"date-time":"2018-10-03T00:54:53Z","timestamp":1538528093000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090825814010531"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,9]]},"references-count":35,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2014,9]]}},"alternative-id":["S0090825814010531"],"URL":"https:\/\/doi.org\/10.1016\/j.ygyno.2014.06.013","relation":{},"ISSN":["0090-8258"],"issn-type":[{"value":"0090-8258","type":"print"}],"subject":[],"published":{"date-parts":[[2014,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prognostic analysis of invasive circulating tumor cells (iCTCs) in epithelial ovarian cancer","name":"articletitle","label":"Article Title"},{"value":"Gynecologic Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ygyno.2014.06.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}